L.E. Makaroff

L.E. Makaroff

Auto-generated profile, based on publicly available information

L.E. Makaroff

International Diabetes Federation, Chaussée de la Hulpe 166, Brussels, Belgium; Department of Microbiology and Immunology, University of Leuven, Herestraat 49, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2014 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
LGLeonor Guariguata
Leonor Guariguata
DWD.R. Whiting
D.R. Whiting
IHI. Hambleton
I. Hambleton
JBJ. Beagley
J. Beagley
ULU. Linnenkamp
U. Linnenkamp
JSJ.E. Shaw
J.E. Shaw

1 June 2017 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
KOK. Ogurtsova
K. Ogurtsova
JFJ.D. da Rocha Fernandes
J.D. da Rocha Fernandes
YHY. Huang
Y. Huang
ULU. Linnenkamp
U. Linnenkamp
LGLeonor Guariguata
Leonor Guariguata
LML.E. Makaroff
L.E. Makaroff

1 February 2014 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
LGLeonor Guariguata
Leonor Guariguata
ULU. Linnenkamp
U. Linnenkamp
JBJ. Beagley
J. Beagley
DWD.R. Whiting
D.R. Whiting
NCN.H. Cho
N.H. Cho

1 July 2016 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
JFJoao da Rocha Fernandes
Joao da Rocha Fernandes
KOKatherine Ogurtsova
Katherine Ogurtsova
ULUte Linnenkamp
Ute Linnenkamp
LGLeonor Guariguata
Leonor Guariguata
TSTill Seuring
Till Seuring
LMLydia E. Makaroff
Lydia E. Makaroff

1 February 2014 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
ULU. Linnenkamp
U. Linnenkamp
LGLeonor Guariguata
Leonor Guariguata
JBJ. Beagley
J. Beagley
DWD.R. Whiting
D.R. Whiting
NCN.H. Cho
N.H. Cho

3 May 2022 in Diabetic Medicine
Verified
Journal Article
Open access
ULUte Linnenkamp
Ute Linnenkamp
GGGregory Gordon Greiner
Gregory Gordon Greiner
BHBurkhard Haastert
Burkhard Haastert
HAHeinke Adamczewski
Heinke Adamczewski
MKMatthias Kaltheuner
Matthias Kaltheuner
AIAndrea Icks
Andrea Icks
Background: Gestational diabetes (GDM) in the short term is associated with various complications during pregnancy; however, in the long run, women have an increased risk of type 2 diabetes mellitus (T2DM). Therefore, short‐ and long‐term follow‐up postpartum is recommended.Methods: We assessed the proportion of postpartum diabetes screening among 12,991 women with their first GDM‐diagnosed pregnancy in the study period in the nationwide German GestDiab register between 2015 and 2017. In addition to assessing prevalence, we assessed if the probability of postpartum screening was associated with maternal characteristics or pregnancy outcomes.Results: In total, 38.2% (95% CI 32.8%–43.7%) of our sample underwent postpartum diabetes screening, irrespective of its timing. Around 50% of women (19.3% of the total sample) undertook the screening in the recommended time frame of 6–12 weeks postpartum. We found that age, native language, pre‐pregnancy BMI, smoking status, number of previous pregnancies, fasting plasma glucose and HbA1c levels as well as previous pregnancies with GDM and treatment with insulin were associated with participation in the postpartum diabetes screening in our sample.Conclusion: In our study, more than 60% of the women with GDM did not participate in postpartum diabetes screening. This is a missed opportunity in a high‐risk population to detect glucose intolerance. Consequently, appropriate interventions to prevent the progression to T2DM cannot be initiated. Further research should investigate barriers and enabling factors and allow developing a multilevel approach for GDM postpartum care.